SCHEMBL29630982

SCHEMBL29630982

CN1C(=O)CCc2cc(C(=O)O)ccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
CYP11B1 P15538 4/20 0.48
CYP11B2 P19099 4/20 0.48
CYP1A2 P05177 2/20 0.48
CYP17A1 P05093 1/20 0.48
CYP19A1 P11511 1/20 0.48
SIRT2 Q8IXJ6 1/20 0.47
GAA P10253 1/20 0.47
SMYD3 Q9H7B4 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SRD5A1 P18405 3/20 0.45
SRD5A2 P31213 3/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA9 Q16790 1/20 0.45
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44
BRD4 O60885 1/20 0.43
CREBBP Q92793 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20894244 1.00 LMNA (0.56) LMNACYP11B1CYP11B2CYP1A2CYP17A1
SCHEMBL3590613 0.87 LMNA (0.56) LMNACYP11B1CYP11B2CYP1A2CYP17A1
SCHEMBL10565741 0.87 MAPT (0.58) LMNACYP11B1CYP11B2CYP1A2CYP17A1
SCHEMBL1965892 0.85 SMYD3 (0.60) LMNAGAASMYD3ALDH1A1MAPT
SCHEMBL31348187 0.85 SMYD3 (0.60) LMNAGAASMYD3ALDH1A1MAPT
SCHEMBL10563001 0.84 TMEM97 (0.46) LMNACYP11B1CYP11B2CYP1A2CYP17A1
SCHEMBL10861761 0.83 MAPT (0.46) CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1
SCHEMBL10569727 0.83 TMEM97 (0.45) LMNACYP11B1CYP11B2CYP1A2CYP17A1
SCHEMBL7317599 0.82 CYP11B2 (0.44) CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1
SCHEMBL8524330 0.82 MAPT (0.52) LMNACYP11B1CYP11B2CYP1A2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025006982-A1 POTENT AND SELECTIVE DOPAMINE D3 RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-01-02 WO disclosed
CN-109563094-B (hetero) aryl-substituted piperidinyl derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2022-03-18 CN disclosed